Lin, Kuan-Ju
Mendell, Jeanne
Davis, John D.
Harnisch, Lutz O.
Funding for this research was provided by:
Regeneron Pharmaceuticals
Article History
Received: 15 February 2024
Accepted: 16 September 2024
First Online: 30 September 2024
Declarations
:
: All studies were conducted in accordance with ethical principles of the Declaration of Helsinki, and were consistent with International Conference on Harmonisation, Good Clinical Practices, and applicable regulatory requirements.
: All participants provided consent prior to enrolling in these studies.
: Kuan-Ju Lin, Jeanne Mendell, John D. Davis, and Lutz Harnisch are all employees of and stockholders in Regeneron Pharmaceuticals, Inc.